{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:53:35Z","timestamp":1777632815980,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.prp.2023.154571","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:23:56Z","timestamp":1685067836000},"page":"154571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["OTUD1 chemosensitizes triple-negative breast cancer to doxorubicin by modulating P16 expression"],"prefix":"10.1016","volume":"247","author":[{"given":"Tao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-0232","authenticated-orcid":false,"given":"Xuli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2023.154571_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.prp.2023.154571_bib2","article-title":"The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.prp.2023.154571_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-022-01498-9","article-title":"The circROBO1\/KLF5\/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154571_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines9080876","article-title":"TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy","volume":"9","author":"Singh","year":"2021","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.prp.2023.154571_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tips.2015.08.009","article-title":"Targeted therapies for triple-negative breast cancer: combating a stubborn disease","volume":"36","author":"Kalimutho","year":"2015","journal-title":"Trends Pharm. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154571_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.prp.2023.154571_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108800","article-title":"Chemoresistance mechanisms of breast cancer and their countermeasures","volume":"114","author":"Ji","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2023.154571_bib8","first-page":"10","article-title":"In Situ shRNA synthesis on DNA-polylactide nanoparticles to treat multidrug resistant breast cancer","volume":"30","author":"Ni","year":"2018","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.prp.2023.154571_bib9","first-page":"563","article-title":"Postgraduate surgical training in South Africa","volume":"75","author":"Mieny","year":"1989","journal-title":"S Afr. Med J."},{"issue":"4","key":"10.1016\/j.prp.2023.154571_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","article-title":"Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Gradishar","year":"2020","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.prp.2023.154571_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2018.05.018","article-title":"microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2","volume":"651","author":"Zeng","year":"2018","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.prp.2023.154571_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.706395","article-title":"E3 ubiquitin ligase-mediated regulation of osteoblast differentiation and bone formation","volume":"9","author":"Shen","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.prp.2023.154571_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu Rev. Biochem"},{"issue":"8","key":"10.1016\/j.prp.2023.154571_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.prp.2023.154571_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00280-020-04046-8","article-title":"The role of deubiquitinating enzymes in cancer drug resistance","volume":"85","author":"Tanguturi","year":"2020","journal-title":"Cancer Chemother. Pharm."},{"issue":"5","key":"10.1016\/j.prp.2023.154571_bib16","first-page":"5417","article-title":"Distinct expression and prognostic value of OTU domain-containing proteins in non-small-cell lung cancer","volume":"18","author":"Deng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154571_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/JVI.02351-20","article-title":"DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication","volume":"95","author":"Wang","year":"2021","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.prp.2023.154571_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41420-022-01119-w","article-title":"Deubiquitylase OTUD1 confers Erlotinib sensitivity in non-small cell lung cancer through inhibition of nuclear translocation of YAP1","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.prp.2023.154571_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111916","article-title":"The deubiquitinase OTUD1 noncanonically suppresses Akt activation through its N-terminal intrinsically disordered region","volume":"42","author":"Fan","year":"2023","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154571_bib20","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.1998.16.3.1197","article-title":"Role of the p16 tumor suppressor gene in cancer","volume":"16","author":"Liggett","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154571_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/ijms23031665","article-title":"Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC","volume":"23","author":"Ferrari","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154571_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms222413571","article-title":"Current advancements of plant-derived agents for triple-negative breast cancer therapy through deregulating cancer cell functions and reprogramming tumor microenvironment","volume":"22","author":"Wu","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154571_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"12","key":"10.1016\/j.prp.2023.154571_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","article-title":"Mitochondria, bioenergetics and apoptosis in cancer","volume":"3","author":"Burke","year":"2017","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154571_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1535-6108(02)00241-6","article-title":"Apoptosis-targeted therapies for cancer","volume":"3","author":"Reed","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2023.154571_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2023.154571_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.701301","article-title":"Caspase-9: a multimodal therapeutic target with diverse cellular expression in human disease","volume":"12","author":"Avrutsky","year":"2021","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.prp.2023.154571_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.7150\/ijbs.68980","article-title":"OTUD1 stabilizes PTEN to inhibit the PI3K\/AKT and TNF-alpha\/NF-kappaB signaling pathways and sensitize ccRCC to TKIs","volume":"18","author":"Liu","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154571_bib29","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.7150\/ijbs.66480","article-title":"RBMS2 chemosensitizes breast cancer cells to doxorubicin by regulating BMF expression","volume":"18","author":"Xu","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"6456","key":"10.1016\/j.prp.2023.154571_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prp.2023.154571_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/bbb\/zbab217","article-title":"A novel EZH2\/NXPH4\/CDKN2A axis is involved in regulating the proliferation and migration of non-small cell lung cancer cells","volume":"86","author":"Yang","year":"2022","journal-title":"Biosci. Biotechnol. Biochem"},{"key":"10.1016\/j.prp.2023.154571_bib32","first-page":"273","article-title":"Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis","volume":"5","author":"Zhang","year":"2007","journal-title":"Cancer Ther."},{"key":"10.1016\/j.prp.2023.154571_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7150\/jca.1.126","article-title":"Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells","volume":"1","author":"Li","year":"2010","journal-title":"J. Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:03:54Z","timestamp":1759734234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823002716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":33,"alternative-id":["S0344033823002716"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154571","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OTUD1 chemosensitizes triple-negative breast cancer to doxorubicin by modulating P16 expression","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154571"}}